Synaptic Inputs of Neural Afferent Pathways to Vasopressin- and Oxytocin-Secreting Neurons of Supraoptic and Paraventricular Hypothalamic Nuclei

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|16|4|276-287

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.16, Iss.4, 2017-02, pp. : 276-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vasopressin Secretion Control: Central Neural Pathways, Neurotransmitters and Effects of Drugs

By  

Current Pharmaceutical Design, Vol. 18, Iss. 30, 2012-10 ,pp. : 4714-4724

Bentham Science Publishers

Access to resources Recommend Favorite

Vasopressin and Oxytocin in Control of the Cardiovascular System

By  

Current Neuropharmacology, Vol. 11, Iss. 2, 2013-03 ,pp. : 218-230

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization of the signal transduction pathways mediating morphine withdrawal-stimulated c-fos expression in hypothalamic nuclei

By Martnez P.J.   Laorden M.L.   Cerezo M.   Martnez-Pinero M.G.   Milanes M.V.  

European Journal of Pharmacology, Vol. 430, Iss. 1, 2001-10 ,pp. : 59-68

Elsevier

Access to resources Recommend Favorite

Sensory Signal Transduction in the Vagal Primary Afferent Neurons

By  

Current Medicinal Chemistry, Vol. 14, Iss. 24, 2007-10 ,pp. : 2554-2563

Bentham Science Publishers

Access to resources Recommend Favorite

The behavioral effect of vasopressin in the ventral hippocampus is antagonized by an oxytocin receptor antagonist

By Paban V.   Alescio-Lautier B.   Devigne C.   Soumireu-Mourat B.  

European Journal of Pharmacology, Vol. 361, Iss. 2, 1998-11 ,pp. : 165-173

Elsevier

Access to resources Recommend Favorite